Prognostic and predictive value of nuclear imaging in endocrine oncology
作者: Giorgio TregliaBernard GoichotLuca GiovanellaElif HindiéAbhishek JhaKarel PacakDavid TaïebThomas WalterAlessio Imperiale
作者单位: 1Clinic of Nuclear Medicine and PET/CT Center, Imaging Institute of Southern Switzerland, Bellinzona, Switzerland
2Health Technology Assessment Unit, Ente Ospedaliero Cantonale, Bellinzona, Switzerland
3Clinical Trial Unit, Ente Ospedaliero Cantonale, Bellinzona, Switzerland
4Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
5Endocrinology and Internal Medicine Department, Hautepierre Hospital, University Hospitals of Strasbourg, Strasbourg, France
6University Hospital and University of Zürich, Zürich, Switzerland
7Nuclear Medicine Department, Haut-Lévêque Hospital, University Hospitals of Bordeaux, University of Bordeaux, Bordeaux, France
8LabEx TRAIL, University of Bordeaux, Bordeaux, France
9Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA
10Nuclear Medicine, La Timone University Hospital, Aix-Marseille University, Marseille, France
11European Cent
刊名: Endocrine: International Journal of Basic and Clinical Endocrinology, 2020, Vol.67 (1), pp.9-19
来源数据库: Springer Nature Journal
DOI: 10.1007/s12020-019-02131-4
关键词: PrognosticPredictiveNuclear medicinePETEndocrinologyNeuroendocrine
原始语种摘要: Abstract(#br)In the last few years, the role and use of medical technologies in (neuro)endocrine oncology has greatly evolved allowing not only important diagnostic information but also prognostic stratification in different clinical situations. The terms “prognostic” and “predictive” are commonly used to describe the relationships between biomarkers and patients’ clinical outcomes but have quite different meaning. The present work discusses the prognostic and predictive value of nuclear medicine imaging. It critically reviews the clinical significance and potential impact of molecular examinations on follow-up and therapeutic strategies in patients with neuroendocrine neoplasms, thyroid tumors, and adrenal malignancies.
全文获取路径: Springer Nature  (合作)
影响因子:2.25 (2012)